{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:14:00Z","timestamp":1792016040728,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jad.2016.03.034","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T17:27:12Z","timestamp":1457630832000},"page":"268-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions"],"prefix":"10.1016","volume":"197","author":[{"given":"Nicola","family":"Veronese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2016.03.034_bib1","first-page":"75","article-title":"A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania","author":"Ae","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","article-title":"Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial","volume":"14","author":"Anand","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib3","first-page":"468","article-title":"Mania associated with donepezil","volume":"24","author":"Benazzi","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2016.03.034_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2016.03.034_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2007.07050724","article-title":"Galantamine for the treatment of cognitive impairments in people with schizophrenia","volume":"165","author":"Buchanan","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/HRP.0000000000000016","article-title":"Neurocognitive correlates of the course of bipolar disorder","volume":"22","author":"Budde","year":"2014","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0006-3223(98)00320-5","article-title":"Donepezil in treatment-resistant bipolar disorder","volume":"45","author":"Burt","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/ajp.147.4.431","article-title":"Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder","volume":"147","author":"Calabrese","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/rheumatology\/ket132","article-title":"Association between serum levels of 25-hydroxyvitamin D and osteoarthritis: a systematic review","volume":"52","author":"Cao","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jad.2016.03.034_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/NDT.S40503","article-title":"A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania","author":"Chen","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2016.03.034_bib11","first-page":"CD003196","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","volume":"10","author":"Cipriani","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2016.03.034_bib12","first-page":"192","article-title":"Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report","volume":"49","author":"De Chiara","year":"2014","journal-title":"Riv. Psichiatr."},{"key":"10.1016\/j.jad.2016.03.034_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2007-12405","article-title":"Memantine acts as a cholinergic stimulant in the mouse hippocampus","volume":"12","author":"Drever","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2016.03.034_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"A double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/JCP.0b013e3181a497d7","article-title":"A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder","volume":"29","author":"Ghaemi","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/gps.1962","article-title":"A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder","author":"Gildengers","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/JGP.0b013e31802dd367","article-title":"Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder","volume":"15","author":"Gildengers","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.conb.2014.06.004","article-title":"Neuromodulation by acetylcholine: examples from schizophrenia and depression","volume":"29","author":"Higley","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jad.2016.03.034_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.jad.2016.03.034_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-5949.2009.00090.x","article-title":"Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study","volume":"15","author":"Iosifescu","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2016.03.034_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1432-2277.2009.00919.x","article-title":"The merits of measuring the quality of clinical trials: is it becoming a Byzantine discussion?","volume":"22","author":"Jadad","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jad.2016.03.034_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2016.03.034_bib23","first-page":"489","article-title":"Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments","volume":"7","author":"Jann","year":"2014","journal-title":"Am. Heal. Drug Benefits"},{"key":"10.1016\/j.jad.2016.03.034_bib24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(72)90956-7","article-title":"Cholinergic reversal of manic symptoms","volume":"1","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.03.034_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jad.2011.06.060","article-title":"Prospective predictors of mood episodes in bipolar disorder","volume":"135","author":"Kam","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e318184fae2","article-title":"Memantine efficacy and safety in patients with acute mania associated with bipolar i disorder\u202f: a pilot evaluation","volume":"32","author":"Keck","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib27","doi-asserted-by":"crossref","unstructured":"Keefe, Malhotra, Meltzer, Kane, Buchanan, Murthy, Sovel, Li, Goldman, 2008. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo\/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology. 33, 1217\u20131228. doi:10.1038\/sj.npp.1301499.","DOI":"10.1038\/sj.npp.1301499"},{"issue":"1-3","key":"10.1016\/j.jad.2016.03.034_bib28","first-page":"237","volume":"107","author":"Kelly","year":"2008","journal-title":"Is donepezil useful for improving cognitive dysfunction in bipolar disorder? Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2016.03.034_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders\u202f: findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S1461145713000825","article-title":"Genotype variant associated with add-on memantine in bipolar II disorder","author":"Lee","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e3280117feb","article-title":"A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia","volume":"22","author":"Lee","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jpsychires.2013.06.017","article-title":"Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder","volume":"47","author":"Lee","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.jad.2016.03.034_bib1010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol"},{"key":"10.1016\/j.jad.2016.03.034_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/brb3.118","article-title":"Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity","volume":"3","author":"Lopes","year":"2013","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2016.03.034_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11920-006-0055-6","article-title":"Pharmacotherapy of bipolar depression: an update","volume":"8","author":"Thase","year":"2006","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2016.03.034_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib37","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2146\/ajhp060399","article-title":"Rivastigmine-induced dystonia","volume":"64","author":"Pavlis","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jad.2016.03.034_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania. A placebo-controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2016.03.034_bib40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11634390-000000000-00000","article-title":"The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence","volume":"26","author":"Sani","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2016.03.034_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1399-5618.2006.00311.x","article-title":"Galantamine treatment of cognitive impairment in bipolar disorder: four cases","volume":"8","author":"Schrauwen","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2006.04.006","article-title":"Galantamine improves cognition in schizophrenic patients stabilized on risperidone","volume":"60","author":"Schubert","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.pra.0000450324.44661.12","article-title":"Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report","volume":"20","author":"Serra","year":"2014","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2016.03.034_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2045125313507737","article-title":"Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: three case histories","volume":"4","author":"Serra","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5498\/wjp.v4.i4.80","article-title":"Memantine: new prospective in bipolar disorder treatment","volume":"4","author":"Serra","year":"2014","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib46","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.4088\/JCP.13m08956","article-title":"Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder","volume":"76","author":"Serra","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JCP.0b013e31829b62ba","article-title":"Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports","volume":"33","author":"Serra","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007967.pub2","article-title":"Acetylcholinesterase inhibitors for schizophrenia","volume":"1","author":"Singh","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2016.03.034_bib49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1991.01810340047006","article-title":"Carbamazepine compared with lithium in the treatment of mania","volume":"48","author":"Small","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0447.2012.01889.x","article-title":"Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder","volume":"126","author":"Soeiro-de-Souza","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2016.03.034_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/WNF.0b013e318059be76","article-title":"Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2","volume":"30","author":"Stip","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jad.2015.01.018","article-title":"The trajectory of neuropsychological dysfunctions in bipolar disorders: a critical examination of a hypothesis","volume":"175","author":"Strejilevich","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.03.034_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania. Treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.03.034_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.2007.01055.x","article-title":"Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis","volume":"116","author":"Torres","year":"2007","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jad.2016.03.034_bib55","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1017\/S1041610212000701","article-title":"A rivastigmine-precipitated manic episode in a patient with Alzheimer-type dementia","volume":"24","author":"Tseng","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jad.2016.03.034_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.05.063","article-title":"The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited","volume":"753","author":"van Enkhuizen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2016.03.034_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0033291700001975","article-title":"Affective disorders in five United States communities","volume":"18","author":"Weissman","year":"1988","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2016.03.034_bib58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.pnpbp.2008.01.008","article-title":"A systematic review of off-label uses of memantine for psychiatric disorders","volume":"32","author":"Zdanys","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715311927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715311927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T22:20:37Z","timestamp":1655245237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715311927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":59,"alternative-id":["S0165032715311927"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2016.03.034","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2016.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}